JP Morgan highlights mixed sentiment for U.S. large-cap biopharma stocks as advancements in obesity drugs and key product launches shape 2025 outlook. Galapagos NV plans to split into two entities ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

**NM signifies a non meaningful value. A dash signifies the data is not available.

Gilead Sciences has shored up its antibody-drug conjugate pipeline by licensing a candidate from German biotech Tubulis in a deal worth up to $415 million. The agreement includes an upfront ...

Lynne Redman of Wickenburg, Arizona passed away peacefully on January 14, 2025, with family and friends by her side. Lynne was born in Denver, Colorado on June 13, 1950, to Lodema (Olson) Hokr and ...

In a phase 2 trial, an antiretroviral combination developed by Gilead Sciences and MSD suppressed HIV with a single weekly oral dose, raising the hope of a new treatment option for patients.

* EPS estimates are Normalized unless otherwise noted.

“People would say ‘Oh, here comes Mr. Frink,'” recalled one of his daughters, Justine Frink-Robinson ... mason and became a fixture of Mount Gilead Baptist Church. In 1969, he was ...

$ 92.21-0.86-0.92% ...